1. Wnt Signaling in Cancer Stem Cell Biology
    Felipe de Sousa e Melo et al, 2016, Cancers CrossRef
  2. null
    Yann Duchartre et al, 2017 CrossRef
  3. Concise Review: Emerging Drugs Targeting Epithelial Cancer Stem-Like Cells
    Mehreen Ahmed et al, 2017, Stem Cells CrossRef
  4. Targeting autophagy in cancer stem cells as an anticancer therapy
    Yuanyuan Lei et al, 2017, Cancer Letters CrossRef
  5. GSK-3β inhibitor 6-bromo-indirubin-3′-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells
    Kunping Liu et al, 2017 CrossRef
  6. Dishevelled 1, a pivotal positive regulator of the Wnt signalling pathway, mediates 5-fluorouracil resistance in HepG2 cells
    Yisong Xu et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  7. Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116
    Egle Kukcinaviciute et al, 2018, J. Cell. Biochem. CrossRef
  8. A DNA-Encoded Library of Chemical Compounds Based on Common Scaffolding Structures Reveals the Impact of Ligand Geometry on Protein Recognition
    Nicholas Favalli et al, 2018, ChemMedChem CrossRef
  9. Quantitative Proteomic Analysis of 2D and 3D Cultured Colorectal Cancer Cells: Profiling of Tankyrase Inhibitor XAV939-Induced Proteome
    Young Eun Kim et al, 2018, Sci Rep CrossRef
  10. XAV939, a Wnt/β-catenin pathway modulator, has inhibitory effects on LPS-induced inflammatory response.
    Jaewoong Jang et al, 2019, Immunopharmacol Immunotoxicol CrossRef
  11. null
    Cristina Albuquerque et al, 2018 CrossRef
  12. Tankyrase: Function and Tankyrase Inhibitor in Cancer
    Mi Kyung Kim, 2018, BSL CrossRef
  13. HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma.
    Yu Wu et al, 2019, Chem Biol Interact CrossRef
  14. WNT Signaling in Cardiac and Vascular Disease.
    Sébastien Foulquier et al, 2018, Pharmacol Rev CrossRef
  15. Investigating the regulation mechanism of baicalin on triple negative breast cancer’s biological network by a systematic biological strategy
    Kailin Yang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  16. Inhibition of WNT signaling reduces differentiation and induces sensitivity to doxorubicin in human malignant neuroblastoma SH-SY5Y cells
    Junjira Suebsoonthron et al, 2017, Anti-Cancer Drugs CrossRef
  17. Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention
    Claudia Gasch et al, 2017, Mol Cancer CrossRef
  18. WNT Signaling and Colorectal Cancer
    Emma M. Schatoff et al, 2017, Curr Colorectal Cancer Rep CrossRef
  19. Targeting Tankyrase to Fight WNT-dependent Tumours
    Tor Espen Thorvaldsen, 2017, Basic Clin Pharmacol Toxicol CrossRef
  20. Macrophages as an Emerging Source of Wnt Ligands: Relevance in Mucosal Integrity
    Jesús Cosin-Roger et al, 2019, Front. Immunol. CrossRef
  21. Poly(ADP-ribose) polymerase enzymes and the maintenance of genome integrity
    Travis Eisemann et al, 2019, Cell. Mol. Life Sci. CrossRef
  22. Downregulation of CXXC Finger Protein 4 Leads to a Tamoxifen-resistant Phenotype in Breast Cancer Cells Through Activation of the Wnt/β-catenin Pathway
    Yijie Fu et al, 2020, Translational Oncology CrossRef
  23. Wnt-β-catenin Signaling Pathway, the Achilles' Heels of Cancer Multidrug Resistance
    Morteza Ghandadi et al, 2019, CPD CrossRef
  24. Inhibition of Wnt signalling pathway by XAV939 enhances radiosensitivity in human cervical cancer HeLa cells
    Jinhua Zhang et al, 2020, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  25. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance
    Feng Luo et al, 2016, Oncotarget CrossRef
  26. Emerging agents that target signaling pathways in cancer stem cells
    Yue Yang et al, 2020, J Hematol Oncol CrossRef
  27. Regulation of poly ADP-ribosylation of VEGF by an interplay between PARP-16 and TNKS-2
    Haritha Kunhiraman et al, 2020, Mol Cell Biochem CrossRef
  28. Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer (Review)
    Emiko Niiro et al, 2018, biom rep CrossRef
  29. DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway
    Feng Jin et al, 2020, Int J Oncol CrossRef
  30. Novel insight into the function of tankyrase (Review)
    Mi Kim, 2018, Oncol Lett CrossRef
  31. Anticancer effect of XAV939 is observed by inhibiting lactose dehydrogenase A in a 3‑dimensional culture of colorectal cancer cells
    Dahee Kim et al, 2019, Oncol Lett CrossRef
  32. Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer
    Till Kaltofen et al, 2020, J Cancer Res Clin Oncol CrossRef
  33. 3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors
    Luned M. Badder et al, 2020, PLoS ONE CrossRef
  34. Bioinformatic analysis reveals the molecular targets of tangeretin in overcoming the resistance of breast cancer to tamoxifen
    Adam Hermawan et al, 2020, Gene Reports CrossRef
  35. Shorter telomere length, higher telomerase activity in association with tankyrase gene polymorphism contribute to high-altitude pulmonary edema
    Manjula Miglani et al, 2020 CrossRef
  36. Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks
    Monica Sharma et al, 2020, IJMS CrossRef
  37. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Ya Zhang et al, 2020, J Hematol Oncol CrossRef
  38. Distinct Colorectal Cancer–Associated APC Mutations Dictate Response to Tankyrase Inhibition
    Emma M. Schatoff et al, 2019, Cancer Discov CrossRef
  39. Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/β-catenin-signaling pathway
    Sirorut Sinnung et al, 2021, Mol Cell Biochem CrossRef
  40. Emerging Strategies for Sensitization of Therapy Resistant Tumors Toward Cancer Therapeutics by Targeting the Bcl-2 Family, TGF-β, Wnt/β-Catenin, RASSF and miRNA Regulated Signaling Pathways
    Veerasamy Tarmarajen et al, 2021, The International Journal of Biochemistry & Cell Biology CrossRef
  41. Seeding drug discovery: Telomeric tankyrase as a pharmacological target for the pathophysiology of high-altitude hypoxia
    Manjula Miglani et al, 2021, Drug Discovery Today CrossRef
  42. Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma
    Jianjia Xiao et al, 2021, Bioengineered CrossRef
  43. The Small Molecule BC-2059 Inhibits Wingless/Integrated (Wnt)-Dependent Gene Transcription in Cancer through Disruption of the Transducin β-Like 1-β-Catenin Protein Complex
    Raffaella Soldi et al, 2021, J Pharmacol Exp Ther CrossRef
  44. The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy
    Zhuo Wang et al, 2021, Biomark Res CrossRef
  45. null
    Evangelos P. Daskalopoulos et al, 2021 CrossRef
  46. Therapeutic Potential of Naturally Occurring Small Molecules to Target the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer
    Luiz F. S. Oliveira et al, 2022, Cancers CrossRef
  47. Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer
    Mingfeng Yu et al, 2022, J. Med. Chem. CrossRef
  48. OCC-1D regulates Wnt signaling pathway: potential role of long noncoding RNA in colorectal cancer
    Fatemeh Yousefi et al, 2022, Mol Biol Rep CrossRef
  49. Deubiquitination of TNKS1 Regulates Wnt/β-Catenin to Affect the Expression of USP25 to Promote the Progression of Glioma
    Bin Tang et al, 2022, Disease Markers CrossRef
  50. ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis
    Lei Wu et al, 2022, Front. Immunol. CrossRef
  51. Expression pattern and clinical significance of β-catenin gene and protein in patients with primary malignant and benign bone tumors
    Narges Khademian et al, 2022, Sci Rep CrossRef
  52. Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis
    Elham Kalantari et al, 2022, Cancer Cell Int CrossRef
  53. Stabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells
    Feng Luo et al, 2022, Cancer Gene Ther CrossRef